EXOZ (invizyne.com) Bozor qiymatining balans qiymatiga nisbati

Invizyne Technologies (EXOZ) kompaniyasining rasmiy ramzlari

eXoZymes Inc (EXOZ) o'zining innovatsion SimpleCell tizimini monetizatsiya qilmoqda, royalti to'lovlari va sanoat gigantlari bilan bevosita kelishuvlar orqali daromad keltirmoqda. Biznes modeli tashqi hamkorlarga hujayrasiz birikmalar sintezi huquqlarini berishga asoslangan. Startap hozirda o'z ishlanmalarini tasdiqlash uchun ilmiy va texnik ittifoqlarni faol shakllantirmoqda, bunda ko'rsatkich 9.82 darajasida turibdi. Kompaniyaning joriy bozor qiymati grafigi GURU.Markets platformasida mavjud.

EXOZ Invizyne: Balans qiymatiga nisbatan bozor qiymati 13.02.2025 - 28.10.2026 oraligʻida

Invizyne Technologies (EXOZ) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari eXoZymes Inc|EXOZ - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Invizyne Technologies, Inc.|EXOZ - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati eXoZymes|EXOZ - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati invizyne.com|EXOZ - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati eXoZymes Inc|EXOZ - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Invizyne Technologies, Inc.|EXOZ - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Invizyne Technologies, Inc.
Kompaniyaning dastlabki tahlili:eXoZymes Inc - EXOZ
Invizyne Technologies, Inc. original mahsuloti

Ushbu koeffitsiyent biznesning bozor qiymatining uning sof aktivlariga nisbatan premiumi yoki diskontini belgilab, fundamental ko'rsatkichlarning qanchalik hadda haddan tashqari baholanganini ochib beradi. Joriy bozor kapitalizatsiyasining balans hisobotiga nisbatini tahlil qilish investorlarning eXoZymes Inc (EXOZ) kompaniyasining hujayrasiz fermentlar sintezi va ishlab chiqarish xarajatlarini kamaytirish bo'yicha strategik ittifoqlarini kompaniya resurslarining haqiqiy qiymatiga nisbatan aslida qanday kapitalizatsiya qilayotganini baholash imkonini beradi.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati Haleon plc (HLN)|KVUE (kenvue.com) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|ABVC: Bozor kapitallashuvining balans qiymatiga nisbati|CPIX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Quantum BioPharma Limited (QNTM) - Kapitallashuvning sof aktivlarga nisbati|FGEN: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati TELO|Bozor qiymatining balans qiymatiga koeffitsiyenti Rani Therapeutics Holdings, Inc.|Kapitallashuvning sof aktivlarga nisbati Synergy CHC Corp. SNYR|Sof aktivlarga nisbatan bozor kapitallashuvi Rallybio Corp. (RLYB)|Lexaria Bioscience - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PULM (Pulmatrix Corporation)|Pheton Holdings - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|IBO: Bozor qiymatining balans qiymatiga koeffitsiyenti|tnfpharma.com - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi cbdMD|PRFX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|LIPO (Lipella Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OPTN (OptiNose Inc)|PIRS - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Procaps Group Corp PROC|PTPI: Bozor kapitallashuvining balans qiymatiga nisbati|QLI - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SLRN|Bozor qiymatining balans qiymatiga koeffitsiyenti TFF Pharmaceuticals Inc.